Ignacio Duran, MD, PhD joins the show to discuss the landscape of established ADCs in urothelial cancer and the challenges of drug development in this setting. Dr. Duran leads the GU oncology section of the medical oncology department at Hospital Universitario Marques de Valdecilla in Santander, Spain.